NOS3 and Obesity: Notably, patients with obesity with an endothelial cell-specific deletion of the ADM receptor display improved insulin sensitivity, which was accompanied by enhanced insulin-stimulated endothelial nitric oxide synthase (eNOS) phosphorylation and increased skeletal muscle perfusion [109].